To assess whether overexpression of GABARAPL1 regulated the growth rate of breast cancer cells, we performed a kinetic viability assay (MTT) using wild-type MCF-7, MCF-7-pcDNA3.1 and two MCF-7-Flag-GEC1-(His)6-expressing clones. Here, GABARAPL1 is linked to breast cancer.